Abstract:Introduction: In the field of solid organ transplantation, two different areas have developed: the use of biomarkers to predict allograft tolerance, and biomarkers for the prediction of allograft rejection. In the present study, we investigate the expression of serum human leucocyte antigen-G5 (HLA-G5) in kidney transplant recipients with different post-transplant time and different immune status, which to predict immune hyporesponsiveness in transplant recipients. Methods: The study was approved by the local ethical committee. All patients with end-stage renal disease underwent kidney transplantation with living-related donor. Eleven kidney transplant recipients with normal renal graft were selected in which the dynamic expression of serum HLA-G5 was detected by ELISA method during pre-transplantation and the first year post-transplantation. Thirty three kidney transplant recipients with normal renal graft were selected divided into three groups that 1˜5 years, 5˜10 years and 10 years later post transplantation. Investigate the expression of serum HLA-G5 in recipients during one year later post transplantation. Twenty recipients with acute rejection were selected as acute rejection group, and ten healthy volunteers were selected as healthy control. Results: The levels of serum HLA-G5 had no significant difference between groups of pre-transplantation and normal control (83.27±21.85 U/mL vs. 77.31±23.00 U/mL, P>0.05), and the same results between groups of a week and a month post-transplantation (90.57±16.61 U/mL vs. 93.28±17.32 U/mL, P>0.05). The levels of serum HLA-G5 in group of 3 months post-transplantation significant higher than group of one month post-transplantation (125.79±17.87 U/mL vs. 93.28±17.32 U/mL, P< 0.001). There were no significant difference among 3 months, 6 months and 12 months post transplantation (125.79±17.87 U/mL vs. 127.15±19.10 U/mL vs. 130.96±29.84 U/mL, P>0.05), and between groups of 1˜5 years and 5˜10years post-transplantation (211.75±28.34 U/mL vs. 273.08±131.49 U/mL, P>0.05), and between groups of 10 years later (294.90±123.00 U/mL) and 5˜10years post transplantation (P>0.05). The levels of serum HLA-G5 in group of 10 years later post-transplantation significant higher than group of 1˜5 years post-transplantation (P< 0.05). The levels of HLA-G5 were significant correlated with the post-transplant time in the first year post-transplantation and in one year later post transplantation (r=0.599, r=0.522, P< 0.01). The levels of serum HLA-G5 in all groups of recipients significant higher than group of acute rejection (67.57±23.55U/mL). Conclusions: This study showed increased serum concentration of HLA-G5 in the patients with long term graft and recipents survival compared with acute rejection, and the levels of HLA-G5 were significant correlated with the post-transplant time, which reflect the degree of immune hyporesponsiveness in anti-renal allograft by recipients. Therefore, monitoring of HLA-G5 in the peripheral blood as a biomarker of tolerance may reflect unresponsiveness to the graft and reflect the immune state of kidney transplant recipients, and may be an important reference to guide post-transplant immunosuppressive therapy.

Detection of Sensitization to HLA Antigens in Long-Term Renal Transplant Recipients and Its Clinical Implication

Factors resulting in HLA humoral sensitization in candidates of renal recipients

Prevalence of anti-HLA antibodies in highly sensitized kidney transplant candidates

Impact of HLA Antibodies on Renal Transplant Patients

Impact of HLA Antibodies on Renal Function in Patients after Renal Transplantiion

Impact of HLA Antibodies on Graft Survival in Long-Term Renal Recipients with Functional Grafts.

The analysis of the factors inducing HLA sensitization in first renal transplant recipients

[Relevance of Posttransplant HLA-II Antibodies Production on Long-Term Survival of Renal Allograft].

Human Leucocyte Antigen-G5 As A Biomarker of Tolerance in Kidney Transplant Recipients Could Reflect the Degree of Immune Hyporesponsiveness

Impact of Alloantibody Strength in Crossmatch Negative DSA Positive Kidney Transplantation

Management experience and effect analysis of highly sensitized recipients before living kidney transplantation

Impairment of Renal Allograft Function by Post-Transplant Anti-Hla Antibodies

Issues of Immunological and Hemodynamic Monitoring Before and During Kidney Transplantation in Sensitized Heart Transplant Recipient

Anti-human leukocyte antigens and anti-major histocompatibility complex class I-related chain A antibody expression in kidney transplantation during a four-year follow-up.

Clinical Analysis of 2520 Renal Transplantations in One Center

Dynamic Analysis of the HLA and MICA Specific Antibody Effect on Renal Allograft Fnnetion

Pre-transplant Impact Factors of Acute Rejection after Kidney Transplantation

High Serum Level of the Soluble CD30 Identifies Chinese Kidney Transplant Recipients at High Risk of Unfavorable Outcome

Direction of Lymphocyte Phenotype in Long Term Renal Transplant Recipients under Low Dosage of Immunosuppressant and Its Clinical Significance

The difference of ELISA and LABScreen in detecting HLA antibodies

Significance of HLA-amino acid residue matching in renal transplantation of sensitized recipients